Washington Dc, DCNCT07089576Now EnrollingIRB Ready

Aortic Arch Aneurysm Clinical Trial in Washington Dc, DC

Access cutting-edge aortic arch aneurysm treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Sponsored by Artivion Inc.

Quick Self-Assessment

See if you qualify for this Washington Dc location

Preparing your pre-screening questions…

Expert Care in Washington Dc

Access aortic arch aneurysm specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related aortic arch aneurysm treatment provided free

Apply for This Washington Dc Location

Check if you qualify for this aortic arch aneurysm clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Washington Dc

    Convenient for DC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Washington Dc site if eligible
  4. 4Begin participation

About This Aortic Arch Aneurysm Study in Washington Dc

The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.

Sponsor: Artivion Inc.

Who Can Participate

Inclusion Criteria

≥18 years of age or ≤80 years of age (male or female) at time of surgery
Patient has one of the following indications for open surgery based on computed tomography angiography (CTA) completed within 90 days of informed consent:
Acute, subacute, or chronic dissection that involves the aortic arch and the descending thoracic aorta, with or without involvement of the ascending aorta
Aneurysm that involves the aortic arch and the descending thoracic aorta, with or without involvement of the ascending aorta
Patient, or patient's legally authorized representative (LAR; in the secondary arm only), provides written informed consent prior to any study procedures
Patient's surgery occurs within 90 days of informed consent Anatomical Inclusion Criteria
Aortic diameter at the intended Arcevo™ LSA anastomosis site is ≥ 21 mm
For Aneurysm with distal sealing (i.e., single stage procedure), aortic diameter at the intended distal sealing zone is between 20-36 mm
For Dissection with distal sealing, aortic diameter at the intended distal sealing zone is between 22-40 mm
LSA branch does not require additional stenting further into the LSA (beyond the Arcevo™ LSA)
The intended LSA sealing zone has a diameter between 8.5 mm and 14.0 mm with a length of at least 10 mm
Absence of dissection, aneurysm, or stenosis in the intended LSA sealing zone
The intended LSA branch position does not interrupt flow to any branch vessel (e.g., left vertebral artery)
Patient does not have computed tomography (CT) evidence of extreme arch or LSA angulation precluding safe passage of the Arcevo™ LSA and delivery system
LSA take-off angle between 15° and 90°
For patients requiring planned extension, there is a ≥ 2 cm distal seal zone for the TEVAR device without a severely angulated descending aorta
For patients requiring planned extension, patient has suitable iliac artery anatomy for safe passage of the TEVAR delivery system General

Exclusion Criteria

Patient is pregnant, or planning to become pregnant during the course of the study; individuals of child-bearing potential must agree to use acceptable methods of contraception during the study
Patient has another medical condition (aside from the arch disease) that, in the opinion of the investigator, reduces the patient's life expectancy to \< 2 years
Patient has an existing aortic stent graft device in the descending aorta that would interact with Arcevo™ LSA
Patient has a medical, social, or psychological problem that, in the opinion of the investigator, could impede the patient's ability to return for follow-up
Patient is unwilling or unable to comply with the follow-up schedule
Patient is institutionalized due to administrative or judicial order
Patient is unwilling to accept blood transfusion or blood product
Patient is currently participating in another interventional clinical study which includes treatment with another investigational product (e.g., device, pharmaceutical or biologic) Medical Exclusion Criteria
Patient is unfit for open surgical repair involving circulatory arrest
Patient is in extreme hemodynamic compromise requiring cardiopulmonary resuscitation (CPR) or substantial inotropic support prior to surgery
Patient has an active systemic infection
Patient has endocarditis or active infection of the aorta
Patient has a freely ruptured aorta
Patient has a history of a bleeding disorder (e.g., hemophilia)
Patient has current end-stage renal disease (e.g., GFR \<30 mL/min)
Patient has a known allergy to Arcevo™ LSA components and TEVAR device components (if required) (nitinol, polyester, platinum-iridium, or polyethylene)
Patient has uncontrollable anaphylaxis to iodinated contrast or other inability to obtain CT angiograms during follow-up
Patient has acute coronary malperfusion
Patient has symptomatic visceral malperfusion

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Washington Dc?

Yes, this clinical trial (NCT07089576) has an active research site in Washington Dc, DC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Aortic Arch Aneurysm Treatment Options in Washington Dc, DC

If you're searching for aortic arch aneurysm treatment options in Washington Dc, DC, this clinical trial (NCT07089576) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced aortic arch aneurysm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all aortic arch aneurysm clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in Washington Dc, DC

See all interstitial cystitis clinical trials recruiting in Washington Dc — not just this study.

Browse Interstitial Cystitis Trials in Washington Dc →

Browse More Trials by Condition

Interstitial Cystitis TrialsAll Conditions →

Ready to Join in Washington Dc?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Washington Dc, DC